Qube Research & Technologies (QRT)
ANVS icon

Qube Research & Technologies (QRT)’s Annovis Bio ANVS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-302
Closed -$5.65K – 4438
2023
Q4 		$5.65K Buy
302
+300
+15,000% +$2.66K ﹤0.01% 3698
2023
Q3 		$19 Buy
+2
New +$25 ﹤0.01% 3886

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $552M AUM 26% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ANVS Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Annovis Bio (ANVS) in Q1 2024, closing a stake of 302 shares — an estimated $5.65K sold.

Qube Research & Technologies (QRT) first reported a position in ANVS in Q3 2023 and held it in 2 quarters. The position peaked at $5.65K in Q4 2023. 32 funds tracked by Wall St. Rank hold ANVS as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Annovis Bio position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 302 Annovis Bio shares in Q1 2024, an estimated $5.65K.
  • Qube Research & Technologies (QRT) first reported a position in Annovis Bio in Q3 2023 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Annovis Bio position peaked at $5.65K in Q4 2023.
  • 32 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.